ecqm.unions

No Vte Prophylaxis Medication Administeredor Ordered Union

Description:

Based On: Union93

Used By:

• CMS108v7,
• CMS190v7

QDM Attributes

InjectableFactorXaInhibitorForVteProphylaxisAdministered

Clinical Focus: This set of values contains codes which identify a select medication-an injectable Factor Xa inhibitor-which is used for VTE prophylaxis.

Data Element Scope: The intent of this data element is to identify patients who are on a select Injectable Factor Xa Inhibitor as prophylaxis for VTE. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Only include codes which represent injectable Factor Xa inhibitor medications. These are RxNorm codes.

Exclusion Criteria: None.

Subject constrained to the Injectable Factor Xa Inhibitor for VTE Prophylaxis

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

InjectableFactorXaInhibitorForVteProphylaxisAdministered

0..*

InjectableFactorXaInhibitorForVteProphylaxisOrder

Clinical Focus: This set of values contains codes which identify a select medication-an injectable Factor Xa inhibitor-which is used for VTE prophylaxis.

Data Element Scope: The intent of this data element is to identify patients who are on a select Injectable Factor Xa Inhibitor as prophylaxis for VTE. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Only include codes which represent injectable Factor Xa inhibitor medications. These are RxNorm codes.

Exclusion Criteria: None.

Subject constrained to the Injectable Factor Xa Inhibitor for VTE Prophylaxis

MedicationOrder: Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set. Timing: The Author dateTime is the time the order is signed. Timing: The Relevant Period addresses: startTime = when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed). stopTime = when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills. Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills). Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

InjectableFactorXaInhibitorForVteProphylaxisOrder

0..*

LowDoseUnfractionatedHeparinForVteProphylaxisAdministered

Clinical Focus: This set of values contains unfractionated heparin medications with strengths that could reasonably be used for VTE prophylaxis.

Data Element Scope: The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.

Exclusion Criteria: Concentrations less than 250 UNT/ML.

Subject constrained to the Low Dose Unfractionated Heparin for VTE Prophylaxis

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

LowDoseUnfractionatedHeparinForVteProphylaxisAdministered

0..*

LowDoseUnfractionatedHeparinForVteProphylaxisOrder

Clinical Focus: This set of values contains unfractionated heparin medications with strengths that could reasonably be used for VTE prophylaxis.

Data Element Scope: The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.

Exclusion Criteria: Concentrations less than 250 UNT/ML.

Subject constrained to the Low Dose Unfractionated Heparin for VTE Prophylaxis

MedicationOrder: Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set. Timing: The Author dateTime is the time the order is signed. Timing: The Relevant Period addresses: startTime = when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed). stopTime = when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills. Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills). Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

LowDoseUnfractionatedHeparinForVteProphylaxisOrder

0..*

LowMolecularWeightHeparinForVteProphylaxisAdministered

Clinical Focus: This set of values represents medications used for VTE prophylaxis. The medications are low molecular weight heparins. The medications included in this value set are administered parenterally.

Data Element Scope: The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Only include RxNorm codes which specifically represent low molecular weight heparins which are administered parenterally.

Exclusion Criteria: None.

Subject constrained to the Low Molecular Weight Heparin for VTE Prophylaxis

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

LowMolecularWeightHeparinForVteProphylaxisAdministered

0..*

LowMolecularWeightHeparinForVteProphylaxisOrder

Clinical Focus: This set of values represents medications used for VTE prophylaxis. The medications are low molecular weight heparins. The medications included in this value set are administered parenterally.

Data Element Scope: The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Only include RxNorm codes which specifically represent low molecular weight heparins which are administered parenterally.

Exclusion Criteria: None.

Subject constrained to the Low Molecular Weight Heparin for VTE Prophylaxis

MedicationOrder: Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set. Timing: The Author dateTime is the time the order is signed. Timing: The Relevant Period addresses: startTime = when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed). stopTime = when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills. Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills). Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

LowMolecularWeightHeparinForVteProphylaxisOrder

0..*

WarfarinAdministered

Clinical Focus: This set of values contains Warfarin medications that are administered to patients to reduce the risk of blood clot formation.

Data Element Scope: The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction. Using the Quality Data Model, this particular element would map to the Medication category.

Inclusion Criteria: Drug forms that are consistent with oral administration should be included: tablets. Only single ingredient.

Exclusion Criteria: None.

Subject constrained to the Warfarin

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

WarfarinAdministered

0..*

WarfarinOrder

Clinical Focus: This set of values contains Warfarin medications that are administered to patients to reduce the risk of blood clot formation.

Data Element Scope: The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction. Using the Quality Data Model, this particular element would map to the Medication category.

Inclusion Criteria: Drug forms that are consistent with oral administration should be included: tablets. Only single ingredient.

Exclusion Criteria: None.

Subject constrained to the Warfarin

MedicationOrder: Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set. Timing: The Author dateTime is the time the order is signed. Timing: The Relevant Period addresses: startTime = when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed). stopTime = when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills. Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills). Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

WarfarinOrder

0..*